Screener
Cytek Biosciences, Inc. CTKB EMEA — Total
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053496
FAQ
- What is Cytek Biosciences, Inc.'s EMEA — total?
- Cytek Biosciences, Inc. (CTKB) reported EMEA — total of $412K in Q2 2026.
- How has Cytek Biosciences, Inc.'s EMEA — total changed year-over-year?
- Cytek Biosciences, Inc.'s EMEA — total decreased by 12.5% year-over-year, from $471K to $412K.
- What does EMEA — total mean?
- This metric captures the aggregate financial performance or total activity volume attributed to the EMEA business segment. It serves as a comprehensive measure of the segment's overall contribution to the company's operational footprint and market presence. By tracking this total, stakeholders can evaluate the scale and relative importance of the EMEA market compared to other global regions.
Ask your AI about Cytek Biosciences, Inc.'s emea — total.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude